Silicon Valley BioTalks

See the following -

Benefits, Challenges and Best Practices of Clinical Trials: Paper vs. Electronic Data Capture

On February 25th 2015, Clinovo hosted the 10th Session of the Silicon Valley BioTalks at HP’s headquarters in Palo Alto. The attendees consisted of life science industry professionals with the sole intent of discussing the benefits, challenges and best practices of paper-based clinical studies vs EDC based studies. To add a valuable experience to the conversation, the event featured a panel of 4 clinical trials professionals... Read More »

Clinical Trial Design Management: Best Practices for Small Budget Studies

ClinCapture  hosted the 12th BioTalks in Park City, UT, on the topic of Clinical Trial Design & Management: Best Practices for Small Budget Studies. This was the first event in the series hosted in the biotech hub of Salt Lake City. The panel discussion gathered experts from CROs and sponsor companies to conduct quality clinical trials in a cost effective manner. Industry experts shared their knowledge on running high quality, small budget clinical trials covering clinical operations to clinical data management and biostatistics...

Read More »

Roche, Medivation, Santen and Biomarin Will Discuss CDISC Implementation Challenges At The Next Silicon Valley BioTalks

Press Release | Clinical Data Interchange Standards Consortium (CDISC) | September 12, 2013

Panel composed of CDISC experts from Roche, Medivation, Santen, Biomarin and Clinovo will discuss and share ideas around the topic: “CDISC for Medical Device Companies: Progress Made and Best Practices from Pharma/Biotech Implementation”. Read More »

CDISC for Medical Device Companies: Progress Made and Best Practices from Pharma/Biotech Implementation

Event Details
Type: 
Open Source Event
Date: 
October 9, 2013 - 6:30pm - 9:00pm
Location: 
Capgemini Offices, South San Francisco
20425 Stevens Creek Blvd
Cupertino, CA 95014
United States

The healthcare industry, as well as regulatory bodies, have been hard at work in the standardization of clinical trial data. The need for data transparency, traceability, and auditability has continued to increase, in line with the cost of studies and the amount of data submitted to the FDA. As a result, much progress has been made in the past decade in creating standards to ease data exchange and interoperability as well as speed up the regulatory review process.

Read More »